Phase 1 Study of [(177)Lu]Lu-NeoB in Patients with Advanced Solid Tumors Overexpressing Gastrin-Releasing Peptide Receptor: Preliminary Safety and Dosimetry Results.
- DOI
- 10.2967/jnumed.125.270411
- Published
- 2026 Feb 2
- Container
- Journal of nuclear medicine : official publication, Society of Nuclear Medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.2967/jnumed.125.270411,
title = {Phase 1 Study of [(177)Lu]Lu-NeoB in Patients with Advanced Solid Tumors Overexpressing Gastrin-Releasing Peptide Receptor: Preliminary Safety and Dosimetry Results.},
author = {Mittra ES and Solnes LB and van der Veldt AAM and Wong J and Aloj L and Heinrich MC and Chen CT and Rowe SP and Brabander T and Pacey S and Aimone P and Pathak D and Blumenstein L and Liu Y and Iagaru A},
year = {2026},
journal = {Journal of nuclear medicine : official publication, Society of Nuclear Medicine},
doi = {10.2967/jnumed.125.270411},
url = {https://doi.org/10.2967/jnumed.125.270411}
}RIS
TY - JOUR TI - Phase 1 Study of [(177)Lu]Lu-NeoB in Patients with Advanced Solid Tumors Overexpressing Gastrin-Releasing Peptide Receptor: Preliminary Safety and Dosimetry Results. AU - Mittra ES AU - Solnes LB AU - van der Veldt AAM AU - Wong J AU - Aloj L AU - Heinrich MC AU - Chen CT AU - Rowe SP AU - Brabander T AU - Pacey S AU - Aimone P AU - Pathak D AU - Blumenstein L AU - Liu Y AU - Iagaru A PY - 2026 JO - Journal of nuclear medicine : official publication, Society of Nuclear Medicine DO - 10.2967/jnumed.125.270411 UR - https://doi.org/10.2967/jnumed.125.270411 ER -
APA
ES, M., LB, S., AAM, V. D. V., J, W., L, A., MC, H., CT, C., SP, R., T, B., S, P., P, A., D, P., L, B., Y, L., & A, I. (2026). Phase 1 Study of [(177)Lu]Lu-NeoB in Patients with Advanced Solid Tumors Overexpressing Gastrin-Releasing Peptide Receptor: Preliminary Safety and Dosimetry Results.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. https://doi.org/10.2967/jnumed.125.270411
Source records
- pubmed · retrieved 2026-09-26T17:10:23.032Z